Clinical trials
Immunoblastic Lymphadenopathy trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 14 |
| Completed | 2 |
| Suspended | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 3 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2 |
| BeiGene | 1 |
| Fudan University | 1 |
| Huijing Wu | 1 |
| Ou Bai, MD/PHD | 1 |
| Peking Union Medical College Hospital | 1 |
| Qingdao University | 1 |
| Shandong Provincial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 20 |
| Lymphoma, Large-Cell, Anaplastic | 7 |
| Lymphoma, T-Cell | 7 |
| Lymphoma, T-Cell, Peripheral | 6 |
| Lymphoma, Extranodal NK-T-Cell | 5 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Enteropathy-Associated T-Cell Lymphoma | 4 |
| Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Recurrence | 3 |
Trials
Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.